42 results
6-K
EX-10.2
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
6-K
EX-10.3
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.2
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
wub6a0e3wu74r3
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-10.1
dpxxnl8ho x0qp
25 Sep 20
Current report (foreign)
4:33pm
6-K
EX-10.3
k3uxgf472s rlc62v
28 May 20
Current report (foreign)
11:56am
6-K
EX-10.3
2nzv9jh 66xzne13
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.4
f2xx 1hvuzjz9qwu
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.2
xhncw4d
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.1
61voegci4
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.3
vg5yltfol38x
31 Jul 17
Current report (foreign)
12:00am
6-K
EX-10.1
jvtqat dz6po9g
31 Jul 17
Current report (foreign)
12:00am
6-K
EX-10.4
td4vtwvgoxi9 86hzt
31 Jul 17
Current report (foreign)
12:00am
6-K
EX-10.2
4td ppcr63u2au
31 Jul 17
Current report (foreign)
12:00am
6-K
EX-10.1
iyx cf09geq1cyt3uxd
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
6-K/A
EX-10.1
yhseu2
25 Feb 13
Current report (foreign) (amended)
12:00am
F-1
EX-10.4
jjtaq5qh3nvk7zm
24 Sep 10
Registration statement (foreign)
12:00am
F-1
EX-10.12
rxzdj qpc
24 Sep 10
Registration statement (foreign)
12:00am